| Health Care Equipment & Supplies Industry | Healthcare Sector | Bronwyn Brophy O'Connor CEO | LSE Exchange | SE0011205202 ISIN |
| SE Country | 1,150 Employees | 6 May 2026 Last Dividend | 17 May 2018 Last Split | - IPO Date |
Vitrolife AB (publ) is a pioneering company specializing in offering innovative products and solutions for assisted reproduction. The company's diverse portfolio is designed to support various aspects of the in vitro fertilization (IVF) process, from sperm processing to embryo transfer and cryopreservation. Established in 1994, Vitrolife has its headquarters in Gothenburg, Sweden. Over the years, it has expanded its presence across the globe, operating in regions such as Europe, the Middle East, India, Africa, Asia, Japan, the Pacific, and the Americas, underscoring its commitment to aiding fertility clinics and patients worldwide.
Vitrolife AB (publ) offers a comprehensive range of products and technologies designed to enhance the efficiency and success rates of assisted reproductive treatments. Below is an overview of their key offerings: